|4Feb 2, 4:30 PM ET

Alland Leila 4

4 · ABEONA THERAPEUTICS INC. · Filed Feb 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Abeona (ABEO) Director Leila Alland Sells 18,065 Shares

What Happened Leila Alland, a director of Abeona Therapeutics, reported an open-market/private sale of 18,065 shares on 2026-02-02. The weighted-average price reported was $5.09, with proceeds of approximately $91,962. The filing states the sale was made to cover tax obligations associated with the vesting of restricted stock awards.

Key Details

  • Transaction date: 2026-02-02
  • Transaction type/code: Sale (S) — reported as open market or private sale
  • Shares sold: 18,065
  • Price: weighted average $5.09; reported range $5.09–$5.12 (sold in multiple transactions) (Footnote F2)
  • Proceeds: ~$91,962
  • Purpose: To cover tax withholding on vested restricted stock awards (Footnote F1)
  • Shares owned after transaction: Not specified in this Form 4 filing
  • Filing timeliness: Reported same day (no late filing indicated)

Context This sale was reported as a tax-related transaction tied to the vesting of restricted stock rather than a discretionary investment decision. Such sales to satisfy tax obligations are common and do not necessarily reflect the insider's view on the company’s prospects. The filer has offered to provide details of the number of shares sold at each price within the reported range upon request (per Footnote F2).

Insider Transaction Report

Form 4
Period: 2026-02-02
Alland Leila
Director
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-02-02$5.09/sh18,065$91,962173,614 total
Footnotes (2)
  • [F1]The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Signature
/s/ Leila Alland|2026-02-02

Documents

1 file
  • 4
    ownership.xmlPrimary

    4